Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs. Corticosteroid vs. Placebo for Basal Joint Arthritis
NCT03196310Terminated
- Sponsor
- Kettering Health
- Start
- Sep 2018
- Primary completion
- Mar 2025
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, single-blind trial of autologous platelet-rich plasma in osteoarthritis (OA) (3 arms), sponsored by Kettering Health. Primary endpoint: Disabilities of the Arm, Shoulder and Hand Score at 1 year. Started Sep 2018; status: terminated.
02
Drugs
autologous platelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03196310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03196310.